Osman S, Danpure H J
MRC Cyclotron Unit, Hammersmith Hospital, London, UK.
Eur J Haematol. 1987 Aug;39(2):125-7. doi: 10.1111/j.1600-0609.1987.tb00741.x.
A simple and rapid in vitro procedure has been developed for selectively radiolabelling erythrocytes in whole blood using 113mIn-tropolonate. A maximum labelling efficiency of 97% was achieved, of which 95.5% was on the erythrocytes after only 5 min incubation of whole blood at room temperature. The optimum amount of tropolone for labelling whole blood was 10 micrograms of tropolone per ml of blood using acid-citrate dextrose (ACD) as the anticoagulant and 50 micrograms of tropolone per ml of blood using heparin. Under these optimum conditions, only 2.5% of the cell-bound 113mIn was released from the labelled cells during a 1 h in vitro incubation in cell-free plasma, irrespective of the anticoagulant used. These results suggest that 113mIn-tropolonate may prove to be a useful in vitro agent for labelling erythrocytes for short-term clinical investigations, especially at centres where 99mTc and 111In are unavailable.
已经开发出一种简单快速的体外程序,用于使用113m铟-托酚酮选择性地对全血中的红细胞进行放射性标记。实现了97%的最大标记效率,其中在室温下将全血仅孵育5分钟后,95.5%的标记在红细胞上。使用酸柠檬酸葡萄糖(ACD)作为抗凝剂时,标记全血的托酚酮最佳量为每毫升血液10微克托酚酮,使用肝素时为每毫升血液50微克托酚酮。在这些最佳条件下,无论使用何种抗凝剂,在无细胞血浆中进行1小时的体外孵育期间,只有2.5%与细胞结合的113m铟从标记细胞中释放出来。这些结果表明,113m铟-托酚酮可能被证明是一种用于短期临床研究标记红细胞的有用体外试剂,特别是在无法获得99m锝和111铟的中心。